MCP
COYA icon

Mirador Capital Partners’s Coya Therapeutics COYA Stock Holding History

Mirador Capital Partners’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,807
Closed -$79.1K – 201
2024
Q4 		$79.1K Sell
13,807
-454
-3% -$3.09K 0.01% 195
2024
Q3 		$92K Sell
14,261
-470
-3% -$2.96K 0.02% 192
2024
Q2 		$89.3K Sell
14,731
-750
-5% -$6.02K 0.02% 184
2024
Q1 		$154K Sell
15,481
-646
-4% -$5.06K 0.03% 189
2023
Q4 		$120K Buy
16,127
+214
+1% +$1.19K 0.03% 180
2023
Q3 		$61.1K Buy
15,913
+552
+4% +$2.19K 0.01% 181
2023
Q2 		$62.5K Buy
+15,361
New +$71.3K 0.01% 185

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Mirador Capital Partners's COYA Position: Q1 2025 in Review

Mirador Capital Partners sold out of Coya Therapeutics (COYA) in Q1 2025, closing a stake of 13,807 shares — an estimated $79.1K sold.

Mirador Capital Partners first reported a position in COYA in Q2 2023 and held it in 7 quarters. The position peaked at $154K in Q1 2024. 26 funds tracked by Wall St. Rank hold COYA as of Q1 2025.

  • Mirador Capital Partners reported no remaining Coya Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Mirador Capital Partners sold 13,807 Coya Therapeutics shares in Q1 2025, an estimated $79.1K.
  • Mirador Capital Partners first reported a position in Coya Therapeutics in Q2 2023 and held it in 7 quarters.
  • Mirador Capital Partners's Coya Therapeutics position peaked at $154K in Q1 2024.
  • 26 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2025.

Based on Mirador Capital Partners's 13F filing for Q1 2025, filed 9 Apr 2025.